The G6PD Gene Hemolytic Anemia Due to G6PD Deficiency Genetic Test is a critical diagnostic tool available at DNA Labs UAE, aimed at identifying individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency. G6PD is an essential enzyme in the body that helps protect red blood cells from damage and premature destruction. A deficiency in G6PD can lead to hemolytic anemia, a condition where red blood cells are destroyed faster than they can be made, causing symptoms like fatigue, jaundice, and in severe cases, kidney failure or death.
This genetic test specifically looks for mutations in the G6PD gene that are responsible for the enzyme deficiency. By examining a small sample of blood or saliva, the test can accurately identify variations in the G6PD gene that may lead to the condition. This information is vital for early diagnosis and management of the disorder, which can significantly improve the quality of life for affected individuals.
The cost of the G6PD Gene Hemolytic Anemia Due to G6PD Deficiency Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the genetic mutations associated with G6PD deficiency. Given the potential health implications of the disorder, this test is an invaluable resource for individuals with a family history of G6PD deficiency or those exhibiting symptoms of hemolytic anemia. Early detection through this genetic test allows for the implementation of preventive measures and appropriate treatment plans, reducing the risk of severe complications associated with the condition.
The TPI1 gene is responsible for encoding the enzyme triosephosphate isomerase, which plays a critical role in glycolysis, the metabolic pathway that converts glucose into energy. Mutations in the TPI1 gene can lead to a rare but severe condition known as triosephosphate isomerase deficiency. This autosomal recessive disorder is characterized by a wide range of symptoms, including hemolytic anemia, neuromuscular impairments, and, in severe cases, early childhood death.
To diagnose this condition, genetic testing is conducted to identify mutations in the TPI1 gene. In the UAE, DNA Labs offers a specific test for this purpose. The test involves analyzing the patient's DNA to detect any abnormalities in the TPI1 gene that could indicate the presence of triosephosphate isomerase deficiency. This genetic test is crucial for early diagnosis and management of the condition, allowing for appropriate treatment plans to be developed.
The cost of the TPI1 gene hemolytic anemia due to triosephosphate isomerase deficiency genetic test at DNA Labs UAE is 4400 AED. Given the complexity and the specialized nature of this test, it represents a significant investment in the health and well-being of individuals at risk of or suspected to have this rare genetic disorder. Early detection through such genetic testing can significantly impact the management of the disease and the quality of life for affected individuals and their families.
The CD59 gene plays a critical role in regulating the immune system's attack on the body's own cells, particularly in protecting red blood cells from being destroyed. Hemolytic anemia CD59-mediated, with or without immune-mediated polyneuropathy, is a rare genetic disorder. It is characterized by the destruction of red blood cells leading to hemolytic anemia and, in some cases, is associated with immune-mediated polyneuropathy, a condition affecting the peripheral nerves.
A genetic test for this condition can identify mutations in the CD59 gene, helping in the diagnosis and management of the disorder. This test is particularly valuable for individuals who present symptoms of hemolytic anemia or unexplained polyneuropathy, as it can confirm the genetic basis of their condition and guide treatment decisions.
DNA Labs UAE offers this specific genetic test. The cost of the test is 4400 AED. Undergoing this test at DNA Labs UAE can provide crucial information for affected individuals and their families, facilitating a better understanding of the condition and enabling healthcare providers to tailor treatments that can significantly improve quality of life and manage symptoms more effectively.
The KEL gene hemolytic anemia Kell-system related genetic test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the KEL gene that are associated with hemolytic anemia within the Kell blood group system. Hemolytic anemia is a condition characterized by the premature destruction of red blood cells, leading to a myriad of health issues, including fatigue, weakness, and more severe complications if left untreated. The Kell blood group system plays a crucial role in this context, as specific genetic variations can trigger the immune system to attack red blood cells.
This test is crucial for individuals suspected of having hemolytic anemia related to the Kell blood group system or for those with a family history of the condition, aiming to provide a definitive diagnosis. By analyzing the DNA for specific mutations in the KEL gene, healthcare providers can better understand the condition's nature and tailor treatment plans to manage symptoms effectively and prevent complications.
The test is priced at 4400 AED and is conducted at DNA Labs UAE, a facility known for its state-of-the-art technology and expertise in genetic diagnostics. The cost reflects the comprehensive nature of the test, encompassing the intricate processes of DNA extraction, amplification, and sequencing, followed by a detailed analysis to identify any genetic abnormalities linked to hemolytic anemia within the Kell system.
For patients and families facing the challenges of hemolytic anemia, this genetic test offers a path to gaining crucial insights into their condition, enabling informed decisions about their health management and treatment options.
The "ACTN1 Gene Bleeding Disorder Platelet-Type 15 Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the ACTN1 gene that are associated with Platelet-Type 15 Bleeding Disorder. This condition is a rare genetic disorder that affects platelet function, leading to bleeding complications. The ACTN1 gene plays a critical role in the formation and stabilization of platelet cytoskeleton, which is essential for proper platelet aggregation and clot formation. Mutations in this gene can disrupt these processes, resulting in increased bleeding risk.
The test is crucial for individuals who have a family history of bleeding disorders or have experienced symptoms such as easy bruising, frequent nosebleeds, heavy menstrual bleeding, or prolonged bleeding from minor wounds. Early diagnosis through this genetic test can facilitate appropriate management strategies and prevent complications.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures accuracy and confidentiality. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to analyze the genetic variations accurately. This investment in health can provide invaluable peace of mind and direction for managing the condition effectively.
The "GFI1B Gene Bleeding Disorder Platelet-Type 17 Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the GFI1B gene, which are associated with Platelet-Type 17 Bleeding Disorder. This condition is a rare genetic disorder that affects the body's ability to form blood clots properly, leading to an increased risk of bleeding. The GFI1B gene plays a crucial role in the development and function of platelets, which are essential for blood clotting. Mutations in this gene can disrupt normal platelet function, resulting in the symptoms associated with this disorder.
The test is designed for individuals who have a clinical history suggestive of a bleeding disorder or for those with a family history of Platelet-Type 17 Bleeding Disorder, aiming to provide a definitive genetic diagnosis. By analyzing the specific DNA sequences of the GFI1B gene, the test can identify mutations that are known to cause the disorder, thereby facilitating accurate diagnosis and enabling targeted management and treatment strategies.
The cost of the test is set at 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results accurately. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, patients can expect a high standard of reliability and confidentiality in the handling of their genetic information. This test represents a critical step for individuals seeking clarity on their genetic predisposition to Platelet-Type 17 Bleeding Disorder, offering them the possibility to take informed steps towards managing their condition effectively.
The "P2RY12 Gene Bleeding Disorder Platelet-Type 8 Genetic Test" is a specialized diagnostic procedure designed to identify mutations in the P2RY12 gene, which are associated with Platelet-Type 8 Bleeding Disorder. This condition is characterized by a defect in platelet function, leading to an increased risk of bleeding. The P2RY12 gene plays a crucial role in the activation of platelets, which are essential for blood clotting. Mutations in this gene can impair platelet function, resulting in symptoms ranging from mild to severe bleeding episodes.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. By analyzing a patient's DNA, the test can detect specific mutations in the P2RY12 gene that are responsible for the disorder. This information is critical for the accurate diagnosis and management of affected individuals, enabling healthcare providers to tailor treatment plans that may include preventive measures against bleeding and recommendations for lifestyle adjustments.
The cost of the P2RY12 Gene Bleeding Disorder Platelet-Type 8 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the test offers invaluable insights into the genetic basis of the patient's condition, facilitating a proactive approach to managing the disorder and improving the patient's quality of life.
SRP72 Gene Bone Marrow Failure Syndrome Type 1 is a rare genetic disorder characterized by the body's inability to produce enough new blood cells in the bone marrow, leading to a variety of health issues including increased risk of infections, anemia, and bleeding complications. This condition is linked to mutations in the SRP72 gene, which plays a crucial role in the biogenesis of ribosomes, essential for protein production in cells.
To diagnose this condition, a genetic test targeting the SRP72 gene can be conducted. This test is crucial for individuals who exhibit symptoms of bone marrow failure or have a family history of the condition, as early diagnosis can significantly influence management and treatment strategies.
In the UAE, the SRP72 Gene Bone Marrow Failure Syndrome Type 1 genetic test is available at DNA Labs UAE, a leading facility specializing in genetic and molecular diagnostics. The test cost is set at 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed in detecting the genetic mutation associated with the syndrome.
Undergoing this test involves providing a DNA sample, usually through a blood draw, which is then analyzed in the laboratory for the presence of mutations in the SRP72 gene. Results from this test can provide valuable information for affected individuals and their families, including the confirmation of the diagnosis, insight into the prognosis, and guidance on potential treatment options and genetic counseling.
In summary, the SRP72 Gene Bone Marrow Failure Syndrome Type 1 genetic test is a specialized diagnostic tool available at DNA Labs UAE for individuals suspected of having or at risk for this rare genetic disorder. With a cost of 4400 AED, the test offers a critical pathway for achieving a definitive diagnosis and facilitating appropriate medical and genetic counseling interventions.
The ERCC6L2 Gene Bone Marrow Failure Syndrome Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the ERCC6L2 gene. These mutations are linked to a rare genetic disorder known as Bone Marrow Failure Syndrome Type 2. This condition can lead to a range of hematological issues, including an increased risk of developing certain types of cancer. The test plays a crucial role in the early detection and management of the syndrome, allowing healthcare providers to tailor treatments and interventions more effectively.
Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, the test involves collecting a DNA sample from the patient, usually through a blood draw. The sample is then analyzed to detect any abnormalities or mutations in the ERCC6L2 gene that could indicate the presence of Bone Marrow Failure Syndrome Type 2.
The cost of the ERCC6L2 Gene Bone Marrow Failure Syndrome Type 2 Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the sophisticated technology and expert analysis required to accurately identify mutations in the ERCC6L2 gene. For patients at risk of this syndrome or exhibiting symptoms related to bone marrow failure, this test provides a critical pathway to understanding their condition and accessing appropriate care.
The "HBG2 Gene Cyanosis Transient Neonatal Genetic Test" is a specialized diagnostic procedure designed to identify genetic mutations in the HBG2 gene, which are associated with transient neonatal cyanosis. Cyanosis refers to a bluish or purplish coloration of the skin and mucous membranes, a condition that is caused by a lack of oxygen in the blood. In newborns, this can be a transient condition, often linked to genetic factors, specifically mutations in the HBG2 gene.
This genetic test involves analyzing the DNA of the newborn to detect any anomalies in the HBG2 gene that could be responsible for the transient cyanosis. Early identification of these mutations allows for prompt and appropriate medical interventions, potentially reducing the risk of complications and guiding the management of the condition.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is set at 4400 AED, reflecting the intricate technology and expertise required to accurately identify mutations in the HBG2 gene. By opting for this test, parents can gain valuable insights into the genetic factors contributing to their newborn's health condition, enabling informed decisions regarding their child's care and treatment.
